Hydrogen sulfide (H₂S) is a gasotransmitter produced endogenously from cysteine metabolism via cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST), and exogenously by sulfate-reducing bacteria (particularly Desulfovibrio and Bilophila wadsworthia) in the gut. At physiological concentrations (nM to low μM range), H₂S functions as a signaling molecule with anti-inflammatory, vasodilatory, and cytoprotective effects; at pathological concentrations (>100 μM), it becomes a mitochondrial poison, inhibiting cytochrome c oxidase and causing severe gastrointestinal and neurological symptoms characteristic of hydrogen sulfide SIBO.
Think of H₂S as a kitchen gas stove: at the right flame level, it's a precise cooking tool that simmers inflammation, relaxes blood vessels, and helps heal wounds. The flame is controlled by three valves (CBS, CSE, 3-MST) that release just enough gas from your cysteine supply tank. But if sulfate-reducing bacteria in your gut start cranking open their own gas lines—like a leaky pipe in the basement—the house fills with toxic fumes. The characteristic rotten egg smell is your smoke detector going off. At low levels, the gas helps regulate the kitchen; at high levels, it poisons the powerhouse (mitochondria), shutting down your energy grid by blocking the final step of the electron transport chain. This is why H₂S SIBO patients feel like someone turned off the lights in every room—brain fog, nausea, total system shutdown. The gas that should be a gentle pilot light has become a suffocating cloud.
Cysteine → CBS/CSE/3-MST → H₂S
Three enzymatic pathways produce H₂S from L-cysteine:
- Cystathionine β-synthase (CBS): Predominantly in brain and liver, requires pyridoxal-5'-phosphate (vitamin B6), converts cysteine + homocysteine → cystathionine + H₂S
- Cystathionine γ-lyase (CSE): Predominantly in cardiovascular system, also B6-dependent, converts cysteine → pyruvate + ammonia + H₂S
- 3-Mercaptopyruvate sulfurtransferase (3-MST): Works with cysteine aminotransferase, produces H₂S in mitochondria and cytoplasm
Physiological H₂S concentration: 10-100 nM in plasma, up to low μM in tissues.
Sulfate-reducing bacteria (SRB) in the gut generate H₂S from:
- Dietary sulfur sources: Sulfate (SO₄²⁻), sulfite preservatives, cruciferous vegetables, eggs, meat
- Sulfur-containing amino acids: Cysteine, methionine, taurine
- Sulfated mucins: Bacteria degrade mucus layer for sulfate substrate
Primary SRB species:
- Desulfovibrio (most common in H₂S SIBO)
- Bilophila wadsworthia (increases with high-fat, high-protein diets)
- Desulfobacter
- Desulfobulbus
The reaction: SO₄²⁻ + organic carbon → H₂S + HCO₃⁻
graph TD
H2S["H₂S Production"] --> A[S-Sulfhydration of Proteins]
A --> B1[KATP Channel Opening]
A --> B2["NF-κB Inhibition"]
A --> B3[Nrf2 Activation]
A --> B4[TRPV1 Channel Block]
B1 --> C1[Vasodilation]
B2 --> C2["↓ Inflammation"]
B3 --> C3["↑ Antioxidant Defense"]
B4 --> C4["↓ Pain Perception"]
H2S --> D["Excess H₂S >100 μM"]
D --> E1[Cytochrome c Oxidase Inhibition]
D --> E2[Chemoreceptor Trigger Zone]
D --> E3["BBB Permeability ↑"]
E1 --> F1[Mitochondrial Shutdown]
E2 --> F2[Severe Nausea/Vomiting]
E3 --> F3[Neurological Symptoms]
At physiological levels (nM-low μM):
- S-sulfhydration: H₂S adds -SSH groups to cysteine residues on target proteins, modulating their function
- K_ATP channel activation → vascular smooth muscle relaxation → vasodilation
- NF-κB inhibition → suppression of pro-inflammatory gene transcription
- Nrf2 activation → upregulation of antioxidant response elements
- TRPV1 channel blockade → reduced nociceptive signaling
- eNOS activation → increased nitric oxide production → angiogenesis
- VEGF upregulation → new blood vessel formation → wound healing
At pathological levels (>100 μM):
- Cytochrome c oxidase (Complex IV) inhibition: H₂S binds to the copper center (CuB) and heme a3, blocking electron transfer → mitochondrial ATP production collapses
- Direct CNS effects: H₂S crosses blood-brain barrier → area postrema stimulation → severe nausea/vomiting
- Glutamatergic disruption: Excess H₂S alters NMDA receptor function → brain fog, cognitive impairment
- Gut motility impairment: High H₂S inhibits smooth muscle contraction → severe constipation or paradoxical diarrhea
H₂S is metabolized by:
- Mitochondrial oxidation: Sulfide quinone oxidoreductase → sulfite → sulfate (excreted in urine)
- Methylation: Thiol S-methyltransferase → dimethylsulfide (exhaled)
- Binding to hemoglobin: Sulfhemoglobin formation (green-tinged blood in severe cases)
- Bismuth complexation: Bismuth subsalicylate forms insoluble bismuth sulfide (black stool in treatment)
H₂S SIBO is the most treatment-resistant SIBO variant, characterized by flat hydrogen/methane breath tests but severe symptoms:
- Hallmark symptoms: Intractable nausea, projectile vomiting, severe brain fog, neurological dysfunction, foul-smelling flatulence (rotten eggs), metallic taste
- Diagnostic challenge: Standard lactulose/glucose breath tests don't measure H₂S; diagnosis is clinical + flat H₂/CH₄ with severe symptoms
- Pathophysiology per cPNI: Represents profound dysbiosis with competitive exclusion of hydrogen- and methane-producing species by sulfate-reducers—a selfish microbiome strategy that poisons the host
Evolutionary mismatch context: High-protein, high-fat Western diets provide excess sulfur substrates. Modern sanitation reduces competitive gut species. Antibiotics preferentially kill aerobic/facultative anaerobes, allowing obligate anaerobes like Desulfovibrio to dominate.
Intervention strategy:
- Antimicrobial phase: Berberine 500 mg TID (targets SRB), oregano oil, bismuth subsalicylate 524 mg BID (binds H₂S)
- Dietary modification: Low-sulfur diet for 4-8 weeks (eliminate cruciferous vegetables, eggs, garlic, onions, high-protein meals, sulfite preservatives)
- Cysteine modulation: Temporarily reduce NAC supplementation (common trigger), monitor protein intake
- Mitochondrial support: CoQ10 200-400 mg/day, B-vitamins (especially B6 as cofactor for CBS/CSE), alpha-lipoic acid
- Microbiome rebalancing: After reduction phase, repopulate with Lactobacillus and Bifidobacterium strains that compete with SRB
Clinical thresholds:
- Plasma H₂S >100 μM: severe toxicity threshold
- Urinary sulfate >800 mg/24h: suggests high H₂S production/metabolism
- Breath H₂S measurement (when available): >3 ppm considered elevated
Connection to metamodels:
- Metamodel 3 (Metabolic System): H₂S directly attacks mitochondrial respiration—ultimate metabolic sabotage
- Metamodel 5 (Microbiome): Exemplifies how dysbiotic shifts create toxic metabolic environments
- Selfish immune system: H₂S suppresses local inflammation, allowing SRB to evade immune clearance while poisoning the host
- H₂S is produced endogenously at 10-100 nM plasma concentration by CBS, CSE, and 3-MST enzymes using cysteine as substrate
- Sulfate-reducing bacteria (Desulfovibrio, Bilophila wadsworthia) produce pathological H₂S levels from dietary sulfur, sulfate, and sulfur-containing amino acids
- H₂S SIBO causes severe nausea/vomiting, brain fog, and neurological symptoms despite flat hydrogen/methane breath tests
- Pathological H₂S (>100 μM) inhibits cytochrome c oxidase (Complex IV), collapsing mitochondrial ATP production
- Characteristic rotten egg smell from amino acid fermentation is diagnostic clue
- Bismuth subsalicylate binds H₂S to form black bismuth sulfide, providing both diagnostic marker (black stool) and therapeutic effect
- At physiological levels, H₂S is anti-inflammatory (inhibits NF-κB), analgesic (blocks TRPV1), and pro-angiogenic (activates VEGF)
- High-protein, high-fat diets increase Bilophila wadsworthia and H₂S production
- H₂S crosses the blood-brain barrier, directly affecting brain stem vomiting centers and causing cognitive dysfunction
- Treatment requires 4-8 week low-sulfur diet plus targeted antimicrobials—most difficult SIBO variant to resolve
- hydrogen sulfide SIBO — pathological bacterial overproduction in small intestine causing severe systemic symptoms
- cysteine — primary amino acid substrate for endogenous H₂S synthesis via transsulfuration pathway
- Desulfovibrio — dominant sulfate-reducing bacteria in H₂S SIBO, outcompetes other gut microbes
- Bilophila wadsworthia — sulfate-reducing bacteria that increases with high-fat diets, produces H₂S
- SIBO — H₂S-producing variant is most severe and treatment-resistant form
- dysbiosis — H₂S SIBO represents extreme dysbiotic state with competitive exclusion dynamics
- mitochondrial dysfunction — H₂S directly inhibits Complex IV, causing ATP production collapse
- cytochrome c oxidase — terminal enzyme in electron transport chain, primary target of H₂S toxicity
- bacterial fermentation — amino acid fermentation by SRB produces H₂S with characteristic odor
- nausea — H₂S directly stimulates chemoreceptor trigger zone in area postrema
- brain fog — H₂S crosses BBB, disrupts glutamatergic signaling and mitochondrial function in neurons
- NAC — N-acetylcysteine provides cysteine substrate, can paradoxically worsen H₂S SIBO
- bismuth — bismuth subsalicylate binds H₂S, forming black bismuth sulfide as therapeutic and diagnostic marker
- berberine — antimicrobial effective against sulfate-reducing bacteria in H₂S SIBO protocols
- inflammation — physiological H₂S suppresses NF-κB and inflammatory cytokine production
- pain — H₂S blocks TRPV1 nociceptors, providing analgesic effect at low concentrations
- angiogenesis — H₂S stimulates VEGF and eNOS, promoting new blood vessel formation
- wound healing — H₂S enhances collagen synthesis and tissue repair at physiological levels
- flatulence — H₂S contributes to foul-smelling intestinal gas, diagnostic of protein fermentation
- methionine — sulfur-containing amino acid metabolized to cysteine, then H₂S
- breath test — H₂S rarely measured; flat H₂/CH₄ with severe symptoms suggests H₂S SIBO
- gut motility — excess H₂S impairs smooth muscle contraction, causing dysmotility
- ATP production — H₂S toxicity collapses oxidative phosphorylation by blocking Complex IV
- NF-κB — transcription factor inhibited by H₂S S-sulfhydration, reducing inflammatory gene expression
- TRPV1 — pain receptor channel blocked by H₂S, explaining analgesic effects
- blood-brain barrier — H₂S crosses BBB, causing neurological symptoms in H₂S SIBO
- nitric oxide — H₂S activates eNOS, increasing NO production for vasodilation
- VEGF — vascular endothelial growth factor upregulated by H₂S, promoting angiogenesis
- Nrf2 — antioxidant transcription factor activated by H₂S at physiological levels
- sulfate — dietary sulfate is substrate for sulfate-reducing bacteria to produce H₂S
- mucins — gut mucus layer degraded by SRB to access sulfated glycoproteins
- area postrema — brainstem vomiting center directly stimulated by circulating H₂S
- CoQ10 — supports mitochondrial Complex III function, may partially compensate for H₂S-induced Complex IV inhibition